Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. J.H.M. (Anke) van den Berg

Speerpunten

Ik ben klinisch moleculair bioloog bij de Afdeling pathologie van het UMCG en onderzoeker in het “Stem cells, Ageing, Leukemia and Lymphoma” (SALL) programma van het Kanker Research Centrum Groningen. In mijn onderzoek focus ik op de moleculaire pathogenese van B cel lymfomen, waarbij het onderzoeken van genomische afwijkingen, genetische susceptibiliteit, de rol van niet coderende RNAs en de interactie tussen tumorcellen en de infiltrerende cellen centraal staan.

Publicaties

Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis

Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma

Elevated serum TARC levels precede classic Hodgkin lymphoma diagnosis by several years

Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity

Core regions in immunoglobulin heavy chain enhancers essential for survival of non-Hodgkin lymphoma cells are identified by a CRISPR interference screen

Inhibition of the glutamate-cysteine ligase catalytic subunit with buthionine sulfoximine enhances the cytotoxic effect of doxorubicin and cyclophosphamide in Burkitt lymphoma cells

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

NEAT1 and CHROMR lncRNAs: a promising diagnostic tool for diffuse large B-cell lymphoma especially in elderly patients

Lees meer

Pers/media

College